The mission of CAS is to bring together industry leaders, healthcare providers, researchers, academics, and investors to connect and collaborate on the discovery, development, manufacturing, and marketing of therapeutic antibodies. Through its programs and services, the CAS serves as a platform fostering communication and collaboration among its members worldwide, in particular those in China and U.S. It also functions as a bridge to accelerate the USFDA approval and marketing of antibody-based therapeutics developed in China.